These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 14629267)

  • 21. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
    Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
    Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.
    Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
    Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients.
    Pruneri G; Ponzoni M; Ferreri AJ; Decarli N; Tresoldi M; Raggi F; Baldessari C; Freschi M; Baldini L; Goldaniga M; Neri A; Carboni N; Bertolini F; Viale G
    Br J Haematol; 2002 Sep; 118(3):817-20. PubMed ID: 12181051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma.
    Kyzas PA; Agnantis NJ; Stefanou D
    Virchows Arch; 2006 Jun; 448(6):768-75. PubMed ID: 16612622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34.
    Miyata Y; Sagara Y; Watanabe S; Asai A; Matsuo T; Ohba K; Hayashi T; Sakai H
    Virchows Arch; 2013 Nov; 463(5):673-9. PubMed ID: 23975255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
    Yang LY; Lu WQ; Huang GW; Wang W
    BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers].
    Charpin-Taranger C; Dales JP; Garcia S; Andrac-Meyer L; Ramuz O; Carpentier-Meunier S; Bonnier P
    Bull Acad Natl Med; 2003; 187(6):1129-45; discussion 1145-6. PubMed ID: 14978873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenesis in endometrial carcinoma: correlation with survival and clinicopathologic risk factors.
    Ozuysal S; Bilgin T; Ozan H; Kara HF; Oztürk H; Ercan I
    Gynecol Obstet Invest; 2003; 55(3):173-7. PubMed ID: 12865598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development.
    Akagi K; Ikeda Y; Sumiyoshi Y; Kimura Y; Kinoshita J; Miyazaki M; Abe T
    Surgery; 2002 Jan; 131(1 Suppl):S109-13. PubMed ID: 11821796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma.
    Marioni G; Staffieri A; Manzato E; Ralli G; Lionello M; Giacomelli L; Prosenikliev V; Marchese-Ragona R; Busnardo A; Bolzetta F; Blandamura S
    Arch Otolaryngol Head Neck Surg; 2011 Feb; 137(2):175-80. PubMed ID: 21339405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type.
    Stefansson IM; Salvesen HB; Immervoll H; Akslen LA
    Histopathology; 2004 May; 44(5):472-9. PubMed ID: 15139995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neo-angiogenesis in immunohistochemical techniques as a prognostic factor in endometrial carcinoma].
    Szymański W; Fórmaniak J; Szymański M; Grabiec M
    Ginekol Pol; 2003 Sep; 74(9):885-91. PubMed ID: 14674140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myeloma.
    Alexandrakis MG; Neonakis IK; Pappa CA; Konsolas I; Kokonozaki M; Vyzoukaki R; Soundoulounaki S; Xekalou A; Sfiridaki K; Tsirakis G
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1503-9. PubMed ID: 25773125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
    Raica M; Cimpean AM; Anghel A
    Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of vascular endothelial growth factor and assessment of microvascular density with CD 34 and endoglin in proliferative endometrium, endometrial hyperplasia, and endometrial carcinoma.
    Erdem O; Erdem M; Erdem A; Memis L; Akyol G
    Int J Gynecol Cancer; 2007; 17(6):1327-32. PubMed ID: 17442020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of angiogenin in pT1-T2 tongue carcinoma neo-angiogenesis and cell proliferation: an exploratory study.
    Marioni G; Staffieri A; Fasanaro E; Stramare R; Giacomelli L; Bernardi E; Val M; Stellini E; de Filippis C; Blandamura S
    J Oral Pathol Med; 2013 Sep; 42(8):606-11. PubMed ID: 23432607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
    Zhou S; Wang GP; Liu C; Zhou M
    BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoglin (CD105) expression in human renal cell carcinoma.
    Sandlund J; Hedberg Y; Bergh A; Grankvist K; Ljungberg B; Rasmuson T
    BJU Int; 2006 Apr; 97(4):706-10. PubMed ID: 16536758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoglin (CD 105) as a potential prognostic factor in neuroblastoma.
    Ćavar S; Jelašić D; Seiwerth S; Milošević M; Hutinec Z; Mišić M
    Pediatr Blood Cancer; 2015 May; 62(5):770-5. PubMed ID: 25683142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.
    Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S
    Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.